References
- Innos K, Paapsi K, Alas I, et al. Evidence of overestimating prostate cancer mortality in Estonia: a population-based study. Scand J Urol. 2022:1–6.
- Nguyen-Nielsen M, Moller H, Tjonneland A, et al. Causes of death in men with prostate cancer: results from the danish prostate cancer registry (DAPROCAdata). Cancer Epidemiol. 2019;59:249–257.
- Loffeler S, Halland A, Weedon-Fekjaer H, et al. High norwegian prostate cancer mortality: evidence of over-reporting. Scand J Urol. 2018;52(2):122–128.
- Ware L. Evidently Cochrane blog [Internet]. evidentlycochrane.net. Evidently Cochrane UK. 2020. [cited 2022]. Available from: https://www.evidentlycochrane.net/teapots-and-unicorns-absence-of-evidence-is-not-evidence-of-absence/.
- Orrason AW, Garmo H, Styrke J, et al. Comparison of relative survival and cause-specific survival in men with prostate cancer according to age and risk category: a nationwide, population-based study. Am J Epidemiol. 2021;190(10):2053–2063.
- Skyrud KD, Bray F, Moller B. A comparison of relative and cause-specific survival by cancer site, age and time since diagnosis. Intl Journal of Cancer. 2014;135(1):196–203.